Notably, in the context of Alzheimer’s disease, research conducted by Du and colleagues revealed that the activation of TRPV4 led to an increase in tau phosphorylation within the cortex and hippocampus of the P301S tauopathy mouse model, exacerbating cognitive decline [74]. The gene discussed is TRPV4; the disease is early-onset autosomal dominant Alzheimer disease.